The epidemiology of ovarian cancer

Gynecologic Oncology

Volumn 43, Issue 1, 1991, Pages 9-23

  Parazzini, Fabio ^a   Franceschi, Silvia ^b,c   La Vecchia, Carlo ^a,d   Fasoli, Monica ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c European Cancer Prevention Organization ^*  (Belgium)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; HORMONE; ORAL CONTRACEPTIVE AGENT;

COFFEE; CONTRACEPTION; DEVELOPING COUNTRY; DIET; EPIDEMIOLOGY; ETIOLOGY; FAMILY HISTORY; GEOGRAPHIC PATHOLOGY; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; MEDICAL RECORD; MENSTRUATION; OVARY CANCER; PARITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOCIAL CLASS;

FEMALE; HUMAN; INCIDENCE; OVARIAN NEOPLASMS; RISK FACTORS; SUPPORT, NON-U.S. GOV'T;

EID: 0026410941     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/0090-8258(91)90003-N     Document Type: Review

References (99)

1. Cancer incidence in five continents, V
2. Cancer incidence and mortality in Europe
3. Estimates of the world-wide frequency of sixteen major cancers in 1980
4. Classification of human ovarian tumors
5. Incidence of the histologic types of ovarian cancer: The U.S. Third National Cancer Survey, 1969–1971
6. Cytosol and nuclear estrogen and progesterone receptors and 17-β-hydroxysteroid dehydrogenase activity in nondiseased tissue and in benign and malignant tumors of the human ovary
7. Persistence and distribution of estrogen receptor in advanced epithelial ovarian carcinoma after chemotherapy
8. Steroid receptors in epithelial ovarian carcinoma: Relation to clinical parameters and survival
9. Clinical significance of estrogen and progestin receptors in ovarian cancer
10. Cancer incidence in five continents, IV
11. Cancer incidence in five continents, III
12. Progress against cancer: Are we winning the war?
13. Population-based case-control study of ovarian cancer in Shanghai
14. The reduction in risk of ovarian cancer associated with oral-contraceptive use
15. Menstrual factors and the risk of epithelial ovarian cancer
16. Nutrient intake and ovarian cancer
17. Does pregnancy protect against ovarian cancer?
18. Risk factors for ovarian cancer: A case-control study
19. Risk factors for epithelial ovarian cancer in Italy
20. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use
21. Epidemiology of cancer of the ovary
22. An epidemiologic study of epithelial carcinoma of the ovary
23. Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer
24. Reproductive factors and risk of ovarian cancer: A prospective study
25. A case control study of carcinoma of the ovary
26. Ovarian cancer: Incidence and case-control study
27. The epidemiology of ovarian cancer in Greece: A case-control study
28. Menopause and ovarian cancer
29. Measuring the separate effects of low parity and its antecedents on the incidence of ovarian cancer
30. An epidemiologic study of the relationship of reproductive experience to cancer of the ovary
31. “Incessant ovulation” and ovarian cancer
32. The woman at risk for developing ovarian cancer
33. Epithelial ovarian cancer and combination oral contraceptives
34. Determinants of ovarian cancer risk. I. Reproductive experiences and family history
35. Events of reproductive life and the incidence of epithelial ovarian cancer
36. Age at first birth and the risk of epithelial ovarian cancer
37. An epidemiologic case-control study of ovarian cancer and reproductive factors
38. Age at first birth and risk of epithelial ovarian cancer
39. The influence of age at first birth and parity on ovarian cancer risk
40. Case-control study of ovarian cancer in Japan
41. Reproductive genetic and dietary risk factors for ovarian cancer
42. Epidemiologic study of malignancies of the ovaries
43. Epithelial ovarian cancer and the ability to conceive
44. A case-control study of epithelial ovarian cancer
45. Incidence of ovarian cancer in relation to the use of oral contraceptives
46. Oral contraceptives and risk of ovarian cancer
47. Factors affecting the association of oral contraceptives and ovarian cancer
48. Oral contraceptive use and the risk of epithelial ovarian cancer
49. Ovarian neoplasms, functional ovarian cysts, and oral contraceptives
50. Oral contraceptive use and malignancies of the genital tract
51. Case-control study of borderline ovarian tumors: Reproductive history and exposure to exogenous female hormones
52. Epithelial ovarian cancer and combined oral contraceptives
53. Oral contraceptive use and the risk of ovarian cancer: Another Italian case-control study
54. On the epidemiology of oral contraceptives and disease
55. Stilboestrol (diethylstilbestrol) and the risk of ovarian cancer
56. Noncontraceptive estrogen use and the occurrence of ovarian cancer
57. Noncontraceptive estrogen use and epithelial ovarian cancer
58. Non contraceptive estrogen use and the occurrence of ovarian cancer
59. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practice
60. International comparisons of mortality rates for cancer of the breast, ovary prostate and colon and per capita food consumption
61. Mortality among California Seventh-Day Adventists for selected cancer sites
62. Cancer risk and life-style: Cancer among Mormons from 1967–1975
63. Meat and fat consumption and cancer mortality: A study of strict religious orders in Britain
64. Nutritional factors and cancers of the breast endometrium and ovary
65. A case-control study of dietary and nondietary factors in ovarian cancer
66. Dietary animal fat in relation to ovarian cancer risk
67. Dietary factors and the risk of epithelial ovarian cancer
68. Nutational risk factors and ovarian cancer
69. Diet and ovarian cancer
70. Lactase persistence and milk consumption as determinants of ovarian cancer risk
71. Galactose consumption and metabolism in relation to the risk of ovarian cancer
72. Alcohol consumption and ovarian cancer risk
73. Alcohol self-administration disrupts reproductive function in female macaque monkeys
74. Breast cancer and alcoholic-beverage consumption
75. Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: Interview study from the Third National Cancer Survey
76. Familial ovarian cancer
77. Familial ovarian cancer: Increasing in frequency?
78. Familial ovarian cancer registry
79. Familial excess of cancer of the ovary and other anatomic sites
80. Hereditary ovarian carcinomas. Biomarker studies
81. Familial ovarian cancer: A population-based case-control study
82. Family history of ovarian cancer patients: A case-control study
83. Cosmetic talc and ovarian cancer
84. Talc and ovarian cancer
85. Personal and environmental characteristics related to epithelial ovarian cancer
86. Factors in the causation and incidence of ovarian cancer
87. Prevention of ovarian cystomas by inhibition of ovulation: A new concept
88. Attempts to stimulate proliferation of the germinal epithelium of the ovary
89. Cell lines derived from human ovarian carcinomas: Growth stimulation by gonadotropic and steroid hormones
90. Risk factors in ovarian cancer of epithelial origin by pathological diagnosis
91. Risk factors for endometrioid, mucinous and serous benign ovarian cysts
92. Coffee and ovarian cancer
93. Coffee drinking and the risk of epithelial ovarian cancer
94. Epithelial ovarian cancer and coffee drinking